Evidence map›Paper›PMID 37344423›Full record

ArticleInternal medicine (Tokyo, Japan)2024

The Combinations of the Patterns of Non-adherence to Anti-platelet Regimen in Stented Patients (PARIS) and Coronary Revascularization Demonstrating Outcome Study in Kyoto (CREDO-Kyoto) Thrombotic and Bleeding Risk Scores on Clinical Outcomes in Patients with Acute Myocardial Infarction.

Daichi Yamashita, Yuichi Saito, Takanori Sato, Tadahiro Matsumoto, Sakuramaru Suzuki, Kan Saito, Shinichi Wakabayashi, Hideki Kitahara, Koichi Sano, Yoshio Kobayashi

Open access · diamondAbstract read
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Daichi YamashitaDepartment of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Japan.
Yuichi SaitoDepartment of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Japan.
Takanori SatoDepartment of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Japan.
Tadahiro MatsumotoDepartment of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Japan.
Sakuramaru SuzukiDepartment of Cardiovascular Medicine, Eastern Chiba Medical Center, Japan.
Kan SaitoDepartment of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Japan.
Shinichi WakabayashiDepartment of Cardiovascular Medicine, Eastern Chiba Medical Center, Japan.
Hideki KitaharaDepartment of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Japan.
Koichi SanoDepartment of Cardiovascular Medicine, Eastern Chiba Medical Center, Japan.
Yoshio KobayashiDepartment of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Japan.
Chiba University · JPTeikyo University Chiba Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective The Patterns of Non-adherence to Anti-platelet Regimen in Stented Patients (PARIS) and Coronary Revascularization Demonstrating Outcome Study in Kyoto (CREDO-Kyoto) thrombotic and bleeding risk scores were established to predict ischemic and bleeding events in patients undergoing percutaneous coronary intervention (PCI). However, whether or not the combination of these risk scores is predictive of clinical outcomes is unclear. Methods This bicenter registry included a total of 1,098 patients with acute myocardial infarction (MI) undergoing primary PCI. Patients were divided into three groups according to the PARIS and CREDO-Kyoto thrombotic and bleeding risk scores. The study endpoints included the rates of both ischemic (cardiovascular death, recurrent MI, and ischemic stroke) and major bleeding (Bleeding Academic Research Consortium type 3 or 5) events at two years. Results Two years after primary PCI, ischemic and major bleeding events occurred in 17.3% and 10.2% of patients, respectively. The higher-risk categories of PARIS and CREDO-Kyoto scores were associated with increased risks of ischemic and bleeding events. The rates of ischemic and major bleeding events progressively increased with the increase in risk categories in the two risk scoring systems. In the receiver operating characteristic curve analysis, the addition of CREDO-Kyoto thrombotic and bleeding risk scores to PARIS scores significantly improved diagnostic ability in predicting ischemic (area under the curve: 0.59 vs. 0.63, p=0.01) and bleeding (area under the curve: 0.65 vs. 0.68, p=0.01) events. Conclusion The combinations of the PARIS and CREDO-Kyoto risk scores might be useful for evaluating ischemic and bleeding risks in patients with acute MI undergoing primary PCI.

Indexed as

Myocardial InfarctionPercutaneous Coronary InterventionThrombosisHemorrhageHumansOutcome Assessment, Health CarePlatelet Aggregation InhibitorsRisk AssessmentRisk FactorsTreatment OutcomePlatelet Aggregation Inhibitorsacute myocardial infarctionpercutaneous coronary interventionrisk score

Identifiers

PMID37344423
PMCPMC10937133
OpenAlexW4381436026

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.